(4-Bromo-2,6-difluorophenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone → (S)-[2,6-difluoro-4-(3-isopropyl-1,1-dioxo-1lambda6-isothiazolidin-2-yl)phenyl][4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone
Reaction equation
[CH:1]([C@@H:4]1[CH2:8][CH2:7][S:6](=[O:10])(=[O:9])[NH:5]1)([CH3:3])[CH3:2].Br[C:12]1[CH:17]=[C:16]([F:18])[C:15]([C:19]([N:21]2[CH2:26][CH2:25][N:24]([C:27]3[C:32]([CH3:33])=[CH:31][C:30]([CH3:34])=[CH:29][N:28]=3)[CH2:23][CH2:22]2)=[O:20])=[C:14]([F:35])[CH:13]=1>>[F:18][C:16]1[CH:17]=[C:12]([N:5]2[C@H:4]([CH:1]([CH3:3])[CH3:2])[CH2:8][CH2:7][S:6]2(=[O:10])=[O:9])[CH:13]=[C:14]([F:35])[C:15]=1[C:19]([N:21]1[CH2:22][CH2:23][N:24]([C:27]2[C:32]([CH3:33])=[CH:31][C:30]([CH3:34])=[CH:29][N:28]=2)[CH2:25][CH2:26]1)=[O:20]Participants
3
Reactant 2
Product 1
Procedure
Using (S)-3-isopropylisothiazolidine 1,1-dioxide (320 mg) described in Preparation Example 6 and (4-bromo-2,6-difluorophenyl) [4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (410 mg) described in Preparation Example 111 and by the reaction and treatment in the same manner as in Example 4, the title compound (36 mg) was obtained.
Workup
- customdescribed in Preparation Example 111 and by the reaction and treatment in the same manner as in Example 4
Sources & evidence
- ORD record
- ord-d6329049d8814c31960322505de43f21
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…